Year |
Citation |
Score |
2020 |
Lu J, Bao W, Li M, Li L, Zhang Z, Alberts I, Brendel M, Cumming P, Lu H, Xiao Z, Zuo C, Guan Y, Zhao Q, Rominger A. Associations of [F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism. Frontiers in Neuroscience. 14: 604. PMID 32694971 DOI: 10.3389/Fnins.2020.00604 |
0.385 |
|
2020 |
Han X, Wu P, Alberts I, Zhou H, Yu H, Bargiotas P, Yakushev I, Wang J, Höglinger G, Förster S, Bassetti C, Oertel W, Schwaiger M, Huang SC, Cumming P, et al. Characterizing the heterogeneous metabolic progression in idiopathic REM sleep behavior disorder. Neuroimage. Clinical. 27: 102294. PMID 32570206 DOI: 10.1016/J.Nicl.2020.102294 |
0.307 |
|
2020 |
Sacher C, Blume T, Beyer L, Biechele G, Sauerbeck J, Eckenweber F, Deussing M, Focke C, Parhizkar S, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Baumann K, Tahirovic S, Kleinberger G, ... ... Cumming P, et al. Asymmetry of fibrillar plaque burden in amyloid mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32414948 DOI: 10.2967/Jnumed.120.242750 |
0.315 |
|
2020 |
Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte HH, et al. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D receptor agonist radioligand study. Translational Psychiatry. 10: 2. PMID 32066718 DOI: 10.1038/S41398-019-0681-5 |
0.366 |
|
2020 |
Beyer L, Brendel M, Scheiwein F, Sauerbeck J, Hosakawa C, Alberts I, Shi K, Bartenstein P, Ishii K, Seibyl J, Cumming P, Rominger A. Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography. Journal of Alzheimer's Disease : Jad. PMID 31985461 DOI: 10.3233/Jad-190818 |
0.311 |
|
2019 |
Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Van Laere K, Kramberger MG, Trost M, Grmek M, Garibotto V, ... ... Cumming P, et al. Metabolic correlates of dopaminergic loss in dementia with lewy bodies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31840326 DOI: 10.1002/Mds.27945 |
0.407 |
|
2019 |
Cumming P, Marton J, Lilius TO, Olberg DE, Rominger A. A Survey of Molecular Imaging of Opioid Receptors. Molecules (Basel, Switzerland). 24. PMID 31752279 DOI: 10.3390/Molecules24224190 |
0.338 |
|
2019 |
Brendel M, Deussing M, Blume T, Kaiser L, Probst F, Overhoff F, Peters F, von Ungern-Sternberg B, Ryazanov S, Leonov A, Griesinger C, Zwergal A, Levin J, Bartenstein P, Yakushev I, ... Cumming P, et al. Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau. Alzheimer's Research & Therapy. 11: 67. PMID 31370885 DOI: 10.1186/S13195-019-0522-Z |
0.339 |
|
2019 |
Kim JH, Choe YS, Cumming P, Son YD, Kim HK, Joo YH, Kim JH. Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: an [ F]fallypride PET and fMRI study. Synapse (New York, N.Y.). PMID 31206840 DOI: 10.1002/Syn.22121 |
0.36 |
|
2019 |
Gründer G, Cumming P. The downside of downregulation. Brain : a Journal of Neurology. 142: 1500-1502. PMID 31135045 DOI: 10.1093/Brain/Awz133 |
0.315 |
|
2018 |
Narayanaswami V, Dahl K, Bernard-Gauthier V, Josephson L, Cumming P, Vasdev N. Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO. Molecular Imaging. 17: 1536012118792317. PMID 30203712 DOI: 10.1177/1536012118792317 |
0.351 |
|
2018 |
Kim JH, Cumming P, Son YD, Kim HK, Joo YH, Kim JH. Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [ F]fallypride PET and functional MRI study. Synapse (New York, N.Y.). PMID 30063263 DOI: 10.1002/Syn.22064 |
0.377 |
|
2018 |
Amato D, Canneva F, Cumming P, Maschauer S, Groos D, Dahlmanns JK, Grömer TW, Chiofalo L, Dahlmanns M, Zheng F, Kornhuber J, Prante O, Alzheimer C, von Hörsten S, Müller CP. A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter. Molecular Psychiatry. PMID 30038229 DOI: 10.1038/S41380-018-0114-5 |
0.32 |
|
2018 |
Veselinović T, Vernaleken I, Janouschek H, Cumming P, Paulzen M, Mottaghy FM, Gründer G. The role of striatal dopamine D receptors in cognitive performance in drug-free patients with schizophrenia. Psychopharmacology. PMID 29717334 DOI: 10.1007/S00213-018-4916-6 |
0.324 |
|
2017 |
Cumming P, Burgher B, Patkar O, Breakspear M, Vasdev N, Thomas P, Liu GJ, Banati R. Sifting through the surfeit of neuroinflammation tracers. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17748786. PMID 29256293 DOI: 10.1177/0271678X17748786 |
0.406 |
|
2017 |
Kanthan M, Cumming P, Hooker JM, Vasdev N. Classics in Neuroimaging: Imaging the Dopaminergic Pathway with PET. Acs Chemical Neuroscience. PMID 28719177 DOI: 10.1021/Acschemneuro.7B00252 |
0.403 |
|
2016 |
Cumming P, Gallinat J. Invited commentary: mapping the alteration in glutamate with GluCEST MRI in a mouse model of dopamine deficiency: An Editorial Highlight for 'Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency'. Journal of Neurochemistry. PMID 27747879 DOI: 10.1111/Jnc.13759 |
0.303 |
|
2016 |
Deutschländer A, la Fougère C, Boetzel K, Albert NL, Gildehaus FJ, Bartenstein P, Xiong G, Cumming P. Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients. Neuroimage. Clinical. 12: 41-6. PMID 27408789 DOI: 10.1016/J.Nicl.2016.06.007 |
0.427 |
|
2016 |
Olberg DE, Bauer N, Andressen KW, Hjørnevik T, Cumming P, Levy FO, Klaveness J, Haraldsen I, Sutcliffe JL. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats. Nuclear Medicine and Biology. 43: 478-489. PMID 27236283 DOI: 10.1016/J.Nucmedbio.2016.05.003 |
0.383 |
|
2016 |
Cumming P, Gryglewski G, Kranz GS, Lanzenberger R. Commentary: The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression. Journal of Affective Disorders. 199: 21-22. PMID 27057649 DOI: 10.1016/J.Jad.2016.03.058 |
0.324 |
|
2016 |
Cumming P. A business of some heat: molecular imaging of phosphodiesterase 5. Journal of Neurochemistry. 136: 220-1. PMID 26990291 DOI: 10.1111/Jnc.13453 |
0.396 |
|
2015 |
Rademacher L, Prinz S, Winz O, Henkel K, Dietrich CA, Schmaljohann J, Mohammadkhani Shali S, Schabram I, Stoppe C, Cumming P, Hilgers RD, Kumakura Y, Coburn M, Mottaghy FM, Gründer G, et al. Effects of Smoking Cessation on Presynaptic Dopamine Function of Addicted Male Smokers. Biological Psychiatry. PMID 26803340 DOI: 10.1016/J.Biopsych.2015.11.009 |
0.331 |
|
2015 |
Schlüter T, Winz O, Henkel K, Eggermann T, Mohammadkhani-Shali S, Dietrich C, Heinzel A, Decker M, Cumming P, Zerres K, Piel M, Mottaghy FM, Vernaleken I. MAOA-VNTR polymorphism modulates context-dependent dopamine release and aggressive behavior in males. Neuroimage. 125: 378-385. PMID 26481676 DOI: 10.1016/J.Neuroimage.2015.10.031 |
0.347 |
|
2015 |
Maschauer S, Haller A, Riss PJ, Kuwert T, Prante O, Cumming P. Specific binding of [(18) F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain. Journal of Neurochemistry. PMID 26386360 DOI: 10.1111/Jnc.13370 |
0.438 |
|
2015 |
Geisler S, Beindorff N, Cremer M, Hoffmann K, Brenner W, Cumming P, Meyer PT, Langen KJ, Fuchs E, Buchert R. Characterization of [(123) I]FP-CIT binding to the dopamine transporter in the striatum of tree shrews by quantitative in vitro autoradiography. Synapse (New York, N.Y.). 69: 497-504. PMID 26126942 DOI: 10.1002/Syn.21838 |
0.422 |
|
2015 |
Brendel M, Jaworska A, Grießinger E, Rötzer C, Burgold S, Gildehaus FJ, Carlsen J, Cumming P, Baumann K, Haass C, Steiner H, Bartenstein P, Herms J, Rominger A. Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models. Plos One. 10: e0116678. PMID 25706990 DOI: 10.1371/Journal.Pone.0116678 |
0.318 |
|
2015 |
Vafaee MS, Gjedde A, Imamirad N, Vang K, Chakravarty MM, Lerch JP, Cumming P. Smoking normalizes cerebral blood flow and oxygen consumption after 12-hour abstention. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 699-705. PMID 25605288 DOI: 10.1038/Jcbfm.2014.246 |
0.305 |
|
2015 |
Deserno L, Beck A, Huys QJ, Lorenz RC, Buchert R, Buchholz HG, Plotkin M, Kumakara Y, Cumming P, Heinze HJ, Grace AA, Rapp MA, Schlagenhauf F, Heinz A. Chronic alcohol intake abolishes the relationship between dopamine synthesis capacity and learning signals in the ventral striatum. The European Journal of Neuroscience. 41: 477-86. PMID 25546072 DOI: 10.1111/Ejn.12802 |
0.317 |
|
2015 |
Cumming P, Maschauer S, Riss PJ, Grill E, Pischetsrieder M, Kuwert T, Prante O. Perturbed Development of Striatal Dopamine Transporters in Fatty Versus Lean Zucker Rats: a Follow-up Small Animal PET Study. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 521-8. PMID 25537092 DOI: 10.1007/S11307-014-0811-7 |
0.397 |
|
2015 |
Cumming P, Skaper D, Kuwert T, Maschauer S, Prante O. Detection of monoamine oxidase a in brain of living rats with [18F]fluoroethyl-harmol PET. Synapse (New York, N.Y.). 69: 57-9. PMID 25229748 DOI: 10.1002/Syn.21785 |
0.384 |
|
2014 |
Jansen NL, Feuerecker R, Becker-Bense S, Zwergal A, Wulff M, Xiong G, Wängler B, Cumming P, Bartenstein P, Dieterich M, la Fougère C. Assessment of cerebral dopamine D 2/3 formula-receptors in patients with bilateral vestibular failure. Journal of Vestibular Research : Equilibrium & Orientation. 24: 403-13. PMID 25564083 DOI: 10.3233/Ves-140526 |
0.361 |
|
2014 |
Schabram I, Henkel K, Mohammadkhani Shali S, Dietrich C, Schmaljohann J, Winz O, Prinz S, Rademacher L, Neumaier B, Felzen M, Kumakura Y, Cumming P, Mottaghy FM, Gründer G, Vernaleken I. Acute and sustained effects of methylphenidate on cognition and presynaptic dopamine metabolism: an [18F]FDOPA PET study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14769-76. PMID 25355228 DOI: 10.1523/Jneurosci.1560-14.2014 |
0.423 |
|
2014 |
Lehner S, Todica A, Vanchev Y, Uebleis C, Wang H, Herrler T, Wängler C, Cumming P, Böning G, Franz WM, Bartenstein P, Hacker M, Brunner S. In vivo monitoring of parathyroid hormone treatment after myocardial infarction in mice with [68Ga]annexin A5 and [18F]fluorodeoxyglucose positron emission tomography. Molecular Imaging. 13. PMID 25249170 DOI: 10.2310/7290.2014.00035 |
0.319 |
|
2014 |
Cumming P. Measuring effects of MDMA (ecstasy) abuse on the rate of cerebral serotonin synthesis. Journal of Neurochemistry. 131: 541-5. PMID 25156194 DOI: 10.1111/Jnc.12848 |
0.334 |
|
2014 |
Rötering S, Deuther-Conrad W, Cumming P, Donat CK, Scheunemann M, Fischer S, Xiong G, Steinbach J, Peters D, Sabri O, Bucerius J, Brust P. Imaging of α7 nicotinic acetylcholine receptors in brain and cerebral vasculature of juvenile pigs with [(18)F]NS14490. Ejnmmi Research. 4: 43. PMID 25136512 DOI: 10.1186/S13550-014-0043-5 |
0.363 |
|
2014 |
Gryglewski G, Lanzenberger R, Kranz GS, Cumming P. Meta-analysis of molecular imaging of serotonin transporters in major depression. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 34: 1096-103. PMID 24802331 DOI: 10.1038/Jcbfm.2014.82 |
0.307 |
|
2014 |
Cumming P, Maschauer S, Riss PJ, Tschammer N, Fehler SK, Heinrich MR, Kuwert T, Prante O. Radiosynthesis and validation of ¹â¸F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 34: 1148-56. PMID 24714035 DOI: 10.1038/Jcbfm.2014.63 |
0.447 |
|
2014 |
Hocke C, Cumming P, Maschauer S, Kuwert T, Gmeiner P, Prante O. Biodistribution studies of two 18F-labeled pyridinylphenyl amides as subtype selective radioligands for the dopamine D3 receptor. Nuclear Medicine and Biology. 41: 223-8. PMID 24480780 DOI: 10.1016/J.Nucmedbio.2013.12.014 |
0.447 |
|
2014 |
Conway CR, Chibnall JT, Cumming P, Mintun MA, Gebara MA, Perantie DC, Price JL, Cornell ME, McConathy JE, Gangwani S, Sheline YI. Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study. Psychiatry Research. 221: 231-9. PMID 24468015 DOI: 10.1016/J.Pscychresns.2014.01.003 |
0.411 |
|
2014 |
Smits R, Fischer S, Hiller A, Deuther-Conrad W, Wenzel B, Patt M, Cumming P, Steinbach J, Sabri O, Brust P, Hoepping A. Synthesis and biological evaluation of both enantiomers of [(18)F]flubatine, promising radiotracers with fast kinetics for the imaging of α4β2-nicotinic acetylcholine receptors. Bioorganic & Medicinal Chemistry. 22: 804-12. PMID 24369841 DOI: 10.1016/J.Bmc.2013.12.011 |
0.321 |
|
2014 |
Brendel M, Delker A, Rötzer C, Böning G, Carlsen J, Cyran C, Mille E, Gildehaus FJ, Cumming P, Baumann K, Steiner H, Haass C, Herms J, Bartenstein P, Rominger A. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET. Neuroimage. 84: 843-53. PMID 24055703 DOI: 10.1016/J.Neuroimage.2013.09.017 |
0.394 |
|
2014 |
Cumming P. PET neuroimaging: the white elephant packs his trunk? Neuroimage. 84: 1094-100. PMID 23959198 DOI: 10.1016/J.Neuroimage.2013.08.020 |
0.334 |
|
2013 |
Schlüter T, Winz O, Henkel K, Prinz S, Rademacher L, Schmaljohann J, Dautzenberg K, Cumming P, Kumakura Y, Rex S, Mottaghy FM, Gründer G, Vernaleken I. The impact of dopamine on aggression: an [18F]-FDOPA PET Study in healthy males. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 16889-96. PMID 24155295 DOI: 10.1523/Jneurosci.1398-13.2013 |
0.386 |
|
2013 |
Kalbitzer J, Kalbitzer U, Knudsen GM, Cumming P, Heinz A. How the cerebral serotonin homeostasis predicts environmental changes: a model to explain seasonal changes of brain 5-HTT as intermediate phenotype of the 5-HTTLPR. Psychopharmacology. 230: 333-43. PMID 24150247 DOI: 10.1007/S00213-013-3308-1 |
0.306 |
|
2013 |
Kumakura Y, Gjedde A, Caprioli D, Kienast T, Beck A, Plotkin M, Schlagenhauf F, Vernaleken I, Gründer G, Bartenstein P, Heinz A, Cumming P. Increased turnover of dopamine in caudate nucleus of detoxified alcoholic patients. Plos One. 8: e73903. PMID 24040111 DOI: 10.1371/Journal.Pone.0073903 |
0.399 |
|
2013 |
Uebleis C, Hellweger S, Laubender RP, Becker A, Sohn HY, Lehner S, Haug A, Bartenstein P, Cumming P, Van Kriekinge SD, Slomka PJ, Hacker M. The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction. The International Journal of Cardiovascular Imaging. 29: 1645-53. PMID 23744128 DOI: 10.1007/S10554-013-0254-2 |
0.315 |
|
2013 |
Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, Mille E, Gildehaus FJ, Carlsen J, Schlichtiger J, Niedermoser S, Wängler B, Cumming P, Steiner H, Herms J, et al. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1127-34. PMID 23729696 DOI: 10.2967/Jnumed.112.114660 |
0.38 |
|
2013 |
Rominger A, Cumming P, Xiong G, Koller G, Förster S, Zwergal A, Karamatskos E, Bartenstein P, La Fougère C, Pogarell O. Effects of acute detoxification of the herbal blend 'Spice Gold' on dopamine D2/3 receptor availability: a [18F]fallypride PET study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1606-10. PMID 23452563 DOI: 10.1016/J.Euroneuro.2013.01.009 |
0.437 |
|
2013 |
Fischer S, Hiller A, Smits R, Hoepping A, Funke U, Wenzel B, Cumming P, Sabri O, Steinbach J, Brust P. Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine--a promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 74: 128-36. PMID 23416407 DOI: 10.1016/J.Apradiso.2013.01.002 |
0.337 |
|
2013 |
Todica A, Brunner S, Böning G, Lehner S, Nekolla SG, Wildgruber M, Übleis C, Wängler C, Sauter M, Klingel K, Cumming P, Bartenstein P, Schirrmacher R, Franz WM, Hacker M. [68Ga]-albumin-PET in the monitoring of left ventricular function in murine models of ischemic and dilated cardiomyopathy: comparison with cardiac MRI. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 441-9. PMID 23408338 DOI: 10.1007/S11307-013-0618-Y |
0.31 |
|
2013 |
Jupp B, Caprioli D, Saigal N, Reverte I, Shrestha S, Cumming P, Everitt BJ, Robbins TW, Dalley JW. Dopaminergic and GABA-ergic markers of impulsivity in rats: evidence for anatomical localisation in ventral striatum and prefrontal cortex. The European Journal of Neuroscience. 37: 1519-28. PMID 23368520 DOI: 10.1111/Ejn.12146 |
0.352 |
|
2013 |
Kienast T, Schlagenhauf F, Rapp MA, Wrase J, Daig I, Buchholz HG, Smolka MN, Gründer G, Kumakura Y, Cumming P, Charlet K, Bartenstein P, Hariri AR, Heinz A. Dopamine-modulated aversive emotion processing fails in alcohol-dependent patients. Pharmacopsychiatry. 46: 130-6. PMID 23364872 DOI: 10.1055/S-0032-1331747 |
0.329 |
|
2013 |
Walter B, Eiselt M, Cumming P, Xiong G, Hinz R, Uthe S, Brust P, Bauer R. Resistance of brain glucose metabolism to thiopental-induced CNS depression in newborn piglets. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 31: 157-64. PMID 23305916 DOI: 10.1016/J.Ijdevneu.2012.12.008 |
0.377 |
|
2013 |
Todica A, Böning G, Lehner S, Weidl E, Cumming P, Wängler C, Nekolla SG, Schwaiger M, Bartenstein P, Schirrmacher R, Hacker M. Positron emission tomography in the assessment of left ventricular function in healthy rats: a comparison of four imaging methods. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 20: 262-74. PMID 23255241 DOI: 10.1007/S12350-012-9663-1 |
0.326 |
|
2013 |
Cumming P, Xiong G, la Fougère C, Rominger A, Bartenstein P, Buchholz HG, Piel M, Rösch F, Gründer G, Vernaleken I. Surrogate markers for cerebral blood flow correlate with [¹â¸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum. Synapse (New York, N.Y.). 67: 199-203. PMID 23239525 DOI: 10.1002/Syn.21630 |
0.443 |
|
2013 |
Vernaleken I, Klomp M, Moeller O, Raptis M, Nagels A, Rösch F, Schaefer WM, Cumming P, Gründer G. Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 745-54. PMID 22906553 DOI: 10.1017/S1461145712000764 |
0.442 |
|
2013 |
Schlagenhauf F, Rapp MA, Huys QJ, Beck A, Wüstenberg T, Deserno L, Buchholz HG, Kalbitzer J, Buchert R, Bauer M, Kienast T, Cumming P, Plotkin M, Kumakura Y, Grace AA, et al. Ventral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligence. Human Brain Mapping. 34: 1490-9. PMID 22344813 DOI: 10.1002/Hbm.22000 |
0.337 |
|
2012 |
Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Pöpperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C, Thon N. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro-Oncology. 14: 1473-80. PMID 23090986 DOI: 10.1093/Neuonc/Nos259 |
0.302 |
|
2012 |
Lehner S, Todica A, Brunner S, Uebleis C, Wang H, Wängler C, Herbach N, Herrler T, Böning G, Laubender RP, Cumming P, Schirrmacher R, Franz W, Hacker M. Temporal changes in phosphatidylserine expression and glucose metabolism after myocardial infarction: an in vivo imaging study in mice. Molecular Imaging. 11: 461-70. PMID 23084247 DOI: 10.2310/7290.2012.00010 |
0.327 |
|
2012 |
Brunner S, Todica A, Böning G, Nekolla SG, Wildgruber M, Lehner S, Sauter M, Ubleis C, Klingel K, Cumming P, Franz WM, Hacker M. Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapy. Ejnmmi Research. 2: 43. PMID 22863174 DOI: 10.1186/2191-219X-2-43 |
0.348 |
|
2012 |
Jansen NL, Graute V, Armbruster L, Suchorska B, Lutz J, Eigenbrod S, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C. MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? European Journal of Nuclear Medicine and Molecular Imaging. 39: 1021-9. PMID 22491781 DOI: 10.1007/S00259-012-2109-9 |
0.305 |
|
2012 |
Mille E, Cumming P, Rominger A, La Fougère C, Tatsch K, Wängler B, Bartenstein P, Böning G. Compensation for cranial spill-in into the cerebellum improves quantitation of striatal dopamine Dâ‚‚/₃ receptors in rats with prolonged [¹â¸F]-DMFP infusions. Synapse (New York, N.Y.). 66: 705-13. PMID 22460766 DOI: 10.1002/Syn.21558 |
0.446 |
|
2012 |
Virdee K, Cumming P, Caprioli D, Jupp B, Rominger A, Aigbirhio FI, Fryer TD, Riss PJ, Dalley JW. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders. Neuroscience and Biobehavioral Reviews. 36: 1188-216. PMID 22342372 DOI: 10.1016/J.Neubiorev.2012.01.009 |
0.43 |
|
2012 |
Cumming P, Borghammer P. Molecular imaging and the neuropathologies of Parkinson's disease. Current Topics in Behavioral Neurosciences. 11: 117-48. PMID 22034053 DOI: 10.1007/7854_2011_165 |
0.321 |
|
2012 |
Rominger A, Cumming P, Xiong G, Koller G, Böning G, Wulff M, Zwergal A, Förster S, Reilhac A, Munk O, Soyka M, Wängler B, Bartenstein P, la Fougère C, Pogarell O. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics. Addiction Biology. 17: 490-503. PMID 22023291 DOI: 10.1111/J.1369-1600.2011.00355.X |
0.406 |
|
2012 |
Borghammer P, Cumming P, Østergaard K, Gjedde A, Rodell A, Bailey CJ, Vafaee MS. Cerebral oxygen metabolism in patients with early Parkinson's disease. Journal of the Neurological Sciences. 313: 123-8. PMID 21975016 DOI: 10.1016/J.Jns.2011.09.010 |
0.322 |
|
2012 |
Ersche KD, Cumming P, Craig KJ, Müller U, Fineberg NA, Bullmore ET, Robbins TW. Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions? Journal of Psychopharmacology (Oxford, England). 26: 887-90. PMID 21746752 DOI: 10.1177/0269881111405363 |
0.307 |
|
2012 |
Deutschlander A, Fougere CL, Xiong GM, Bötzel K, Gründer G, Cumming P. Therapeutic Occupancy of the D2/3-Preferring Dopamine Receptor Agonist Pramipexol in Brains of Patients with Parkinson's Disease ([18F]-Fallypride PET Study) (P03.126) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.126 |
0.42 |
|
2012 |
Rominger A, Brendel M, Baumann K, Gildehaus F, Niedermoser S, Wängler B, Burgold S, Herms J, Cumming P, Steiner H, Haass C, Bartenstein P. Longitudinal imaging of cerebral beta-amyloid in APP-swe mice using [18F]florbetaben PET Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.411 |
0.317 |
|
2012 |
Rominger A, Brendel M, Baumann K, Gildehaus F, Niedermoser S, Wängler B, Burgold S, Herms J, Cumming P, Steiner H, Haass C, Bartenstein P. Longitudinal imaging of cerebral Aβ in APP-Swe mice using [18F]florbetaben PET Alzheimers & Dementia. 8: 11. DOI: 10.1016/J.Jalz.2012.05.033 |
0.333 |
|
2011 |
Deuther-Conrad W, Fischer S, Hiller A, Becker G, Cumming P, Xiong G, Funke U, Sabri O, Peters D, Brust P. Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹â¸F]NS10743. European Journal of Nuclear Medicine and Molecular Imaging. 38: 1541-9. PMID 21484373 DOI: 10.1007/S00259-011-1808-Y |
0.35 |
|
2011 |
Cumming P. Absolute abundances and affinity states of dopamine receptors in mammalian brain: A review. Synapse (New York, N.Y.). 65: 892-909. PMID 21308799 DOI: 10.1002/Syn.20916 |
0.376 |
|
2011 |
Palner M, Kjaerby C, Knudsen GM, Cumming P. Effects of unilateral 6-OHDA lesions on [3H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat. Neurochemistry International. 58: 243-7. PMID 21163313 DOI: 10.1016/J.Neuint.2010.12.007 |
0.412 |
|
2011 |
Uebleis C, Ulbrich M, Tegtmeyer R, Schuessler F, Haserueck N, Siebermair J, Becker C, Nekolla S, Cumming P, Bartenstein P, Kääb S, Hacker M. Electrocardiogram-gated 18F-FDG PET/CT hybrid imaging in patients with unsatisfactory response to cardiac resynchronization therapy: initial clinical results. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 67-71. PMID 21149479 DOI: 10.2967/Jnumed.110.078709 |
0.334 |
|
2011 |
Cumming P, Caprioli D, Dalley JW. What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction? British Journal of Pharmacology. 163: 1586-604. PMID 20846139 DOI: 10.1111/J.1476-5381.2010.01036.X |
0.363 |
|
2010 |
Förster S, Vaitl A, Teipel SJ, Yakushev I, Mustafa M, la Fougère C, Rominger A, Cumming P, Bartenstein P, Hampel H, Hummel T, Buerger K, Hundt W, Steinbach S. Functional representation of olfactory impairment in early Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 22: 581-91. PMID 20847402 DOI: 10.3233/Jad-2010-091549 |
0.309 |
|
2010 |
Rominger A, Mille E, Zhang S, Böning G, Förster S, Nowak S, Gildehaus FJ, Wängler B, Bartenstein P, Cumming P. Validation of the octamouse for simultaneous 18F-fallypride small-animal PET recordings from 8 mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1576-83. PMID 20847158 DOI: 10.2967/Jnumed.110.078451 |
0.377 |
|
2010 |
Bartmann H, Fuest C, la Fougere C, Xiong G, Just T, Schlichtiger J, Winter P, Böning G, Wängler B, Pekcec A, Soerensen J, Bartenstein P, Cumming P, Potschka H. Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy. Epilepsia. 51: 1780-90. PMID 20633036 DOI: 10.1111/J.1528-1167.2010.02671.X |
0.359 |
|
2010 |
Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 951-60. PMID 20392299 DOI: 10.1017/S1461145710000374 |
0.41 |
|
2010 |
Rominger A, Mille E, Böning G, Wängler B, Josef Gildehaus F, Arszol C, Bartenstein P, Cumming P. α2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse. Synapse (New York, N.Y.). 64: 654-7. PMID 20336625 DOI: 10.1002/Syn.20785 |
0.395 |
|
2010 |
la Fougère C, Pöpperl G, Levin J, Wängler B, Böning G, Uebleis C, Cumming P, Bartenstein P, Bötzel K, Tatsch K. The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 581-7. PMID 20237026 DOI: 10.2967/Jnumed.109.071811 |
0.414 |
|
2010 |
Gjedde A, Kumakura Y, Cumming P, Linnet J, Møller A. Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking. Proceedings of the National Academy of Sciences of the United States of America. 107: 3870-5. PMID 20133675 DOI: 10.1073/Pnas.0912319107 |
0.38 |
|
2010 |
Minuzzi L, Cumming P. Agonist binding fraction of dopamine D2/3 receptors in rat brain: a quantitative autoradiographic study. Neurochemistry International. 56: 747-52. PMID 20117160 DOI: 10.1016/J.Neuint.2010.01.010 |
0.421 |
|
2010 |
Rominger A, Wagner E, Mille E, Böning G, Esmaeilzadeh M, Wängler B, Gildehaus FJ, Nowak S, Bruche A, Tatsch K, Bartenstein P, Cumming P. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse. Synapse (New York, N.Y.). 64: 313-22. PMID 19957365 DOI: 10.1002/Syn.20730 |
0.473 |
|
2010 |
Kumakura Y, Danielsen EH, Gjedde A, Vernaleken I, Buchholz HG, Heinz A, Gründer G, Bartenstein P, Cumming P. Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease. Neuroimage. 49: 2933-9. PMID 19941962 DOI: 10.1016/J.Neuroimage.2009.11.035 |
0.411 |
|
2010 |
Förster S, Teipel S, Zach C, Rominger A, Cumming P, Fougere Cl, Yakushev I, Haslbeck M, Hampel H, Bartenstein P, Bürger K. FDG-PET mapping the brain substrates of visuo-constructive processing in Alzheimer's disease. Journal of Psychiatric Research. 44: 462-9. PMID 19875130 DOI: 10.1016/J.Jpsychires.2009.09.012 |
0.309 |
|
2010 |
la Fougère C, Böning G, Bartmann H, Wängler B, Nowak S, Just T, Wagner E, Winter P, Rominger A, Förster S, Gildehaus FJ, Rosa-Neto P, Minuzzi L, Bartenstein P, Potschka H, ... Cumming P, et al. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar. Neuroimage. 49: 1406-15. PMID 19796699 DOI: 10.1016/J.Neuroimage.2009.09.048 |
0.402 |
|
2010 |
Ostergaard SD, Alstrup AK, Gramsbergen JB, Minuzzi L, Pedersen K, Jensen SB, Doudet D, Cumming P. MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion. Synapse (New York, N.Y.). 64: 70-82. PMID 19768811 DOI: 10.1002/Syn.20706 |
0.41 |
|
2010 |
Yakushev IY, Dupont E, Buchholz HG, Tillmanns J, Debus F, Cumming P, Heimann A, Fellgiebel A, Luhmann HJ, Landvogt C, Werhahn KJ, Schreckenberger M, Potschka H, Bartenstein P. In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy. Epilepsia. 51: 415-22. PMID 19694792 DOI: 10.1111/J.1528-1167.2009.02272.X |
0.443 |
|
2010 |
Kumakura Y, Vernaleken I, Buchholz HG, Borghammer P, Danielsen E, Gründer G, Heinz A, Bartenstein P, Cumming P. Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study. Neurobiology of Aging. 31: 447-63. PMID 18541344 DOI: 10.1016/J.Neurobiolaging.2008.05.005 |
0.412 |
|
2009 |
Kumakura Y, Cumming P. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 15: 635-50. PMID 19793723 DOI: 10.1177/1073858409338217 |
0.423 |
|
2009 |
Borghammer P, Cumming P, Aanerud J, Förster S, Gjedde A. Subcortical elevation of metabolism in Parkinson's disease--a critical reappraisal in the context of global mean normalization. Neuroimage. 47: 1514-21. PMID 19465133 DOI: 10.1016/J.Neuroimage.2009.05.040 |
0.3 |
|
2009 |
Mörtberg E, Cumming P, Wiklund L, Rubertsson S. Cerebral metabolic rate of oxygen (CMRO2) in pig brain determined by PET after resuscitation from cardiac arrest. Resuscitation. 80: 701-6. PMID 19395145 DOI: 10.1016/J.Resuscitation.2009.03.005 |
0.361 |
|
2009 |
Kalbitzer J, Frokjaer VG, Erritzoe D, Svarer C, Cumming P, Nielsen FA, Hashemi SH, Baaré WF, Madsen J, Hasselbalch SG, Kringelbach ML, Mortensen EL, Knudsen GM. The personality trait openness is related to cerebral 5-HTT levels. Neuroimage. 45: 280-5. PMID 19135154 DOI: 10.1016/J.Neuroimage.2008.12.001 |
0.329 |
|
2008 |
Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, et al. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone). Journal of Clinical Psychopharmacology. 28: 608-17. PMID 19011428 DOI: 10.1097/Jcp.0B013E31818Ba2F6 |
0.358 |
|
2008 |
Kienast T, Hariri AR, Schlagenhauf F, Wrase J, Sterzer P, Buchholz HG, Smolka MN, Gründer G, Cumming P, Kumakura Y, Bartenstein P, Dolan RJ, Heinz A. Dopamine in amygdala gates limbic processing of aversive stimuli in humans. Nature Neuroscience. 11: 1381-2. PMID 18978778 DOI: 10.1038/Nn.2222 |
0.355 |
|
2008 |
Vernaleken I, Cumming P, Gründer G. Imaging studies - differential action of typical and atypical antipsychotics in a network perspective. Pharmacopsychiatry. 41: S60-9. PMID 18756422 DOI: 10.1055/S-0028-1082058 |
0.36 |
|
2008 |
Jensen SB, Di Santo R, Olsen AK, Pedersen K, Costi R, Cirilli R, Cumming P. Synthesis and cerebral uptake of 1-(1-[(11)C]methyl-1H-pyrrol-2-yl)-2-phenyl-2-(1-pyrrolidinyl)ethanone, a novel tracer for positron emission tomography studies of monoamine oxidase type A. Journal of Medicinal Chemistry. 51: 1617-22. PMID 18307289 DOI: 10.1021/Jm701378E |
0.417 |
|
2008 |
Vernaleken I, Kumakura Y, Buchholz HG, Siessmeier T, Hilgers RD, Bartenstein P, Cumming P, Gründer G. Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects. Neuroimage. 40: 1222-31. PMID 18262797 DOI: 10.1016/J.Neuroimage.2007.12.045 |
0.406 |
|
2008 |
Borghammer P, Jonsdottir KY, Cumming P, Ostergaard K, Vang K, Ashkanian M, Vafaee M, Iversen P, Gjedde A. Normalization in PET group comparison studies--the importance of a valid reference region. Neuroimage. 40: 529-40. PMID 18258457 DOI: 10.1016/J.Neuroimage.2007.12.057 |
0.324 |
|
2008 |
Kienast T, Siessmeier T, Wrase J, Braus DF, Smolka MN, Buchholz HG, Rapp M, Schreckenberger M, Rösch F, Cumming P, Gruender G, Mann K, Bartenstein P, Heinz A. Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli. European Journal of Nuclear Medicine and Molecular Imaging. 35: 1147-58. PMID 18202844 DOI: 10.1007/S00259-007-0683-Z |
0.381 |
|
2008 |
Landvogt C, Mengel E, Bartenstein P, Buchholz HG, Schreckenberger M, Siessmeier T, Scheurich A, Feldmann R, Weglage J, Cumming P, Zepp F, Ullrich K. Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 824-31. PMID 17971791 DOI: 10.1038/Sj.Jcbfm.9600571 |
0.375 |
|
2008 |
Borghammer P, Vafaee M, Ostergaard K, Rodell A, Bailey C, Cumming P. Effect of memantine on CBF and CMRO2 in patients with early Parkinson's disease. Acta Neurologica Scandinavica. 117: 317-23. PMID 17927800 DOI: 10.1111/J.1600-0404.2007.00943.X |
0.354 |
|
2008 |
Linnet J, Møller A, Kumakura Y, Cumming P, Gjedde A. Low dopamine receptor availability in brain of highly sensation-seeking men Neuroimage. 41: T131. DOI: 10.1016/J.Neuroimage.2008.04.099 |
0.373 |
|
2007 |
Kumakura Y, Cumming P, Vernaleken I, Buchholz HG, Siessmeier T, Heinz A, Kienast T, Bartenstein P, Gründer G. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8080-7. PMID 17652599 DOI: 10.1523/Jneurosci.0805-07.2007 |
0.407 |
|
2007 |
Mörtberg E, Cumming P, Wiklund L, Wall A, Rubertsson S. A PET study of regional cerebral blood flow after experimental cardiopulmonary resuscitation. Resuscitation. 75: 98-104. PMID 17499906 DOI: 10.1016/J.Resuscitation.2007.03.020 |
0.344 |
|
2007 |
Gramsbergen JB, Cumming P. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats. Neurochemistry International. 51: 8-15. PMID 17475367 DOI: 10.1016/J.Neuint.2007.03.004 |
0.309 |
|
2007 |
Lind NM, Moustgaard A, Jelsing J, Vajta G, Cumming P, Hansen AK. The use of pigs in neuroscience: modeling brain disorders. Neuroscience and Biobehavioral Reviews. 31: 728-51. PMID 17445892 DOI: 10.1016/J.Neubiorev.2007.02.003 |
0.32 |
|
2007 |
Cumming P, Møller M, Benda K, Minuzzi L, Jakobsen S, Jensen SB, Pakkenberg B, Stark AK, Gramsbergen JB, Andreasen MF, Olsen AK. A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on serotonin markers in Göttingen minipig brain. Synapse (New York, N.Y.). 61: 478-87. PMID 17415793 DOI: 10.1002/Syn.20377 |
0.4 |
|
2007 |
Mezzomo K, Cumming P, Minuzzi L. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography. European Journal of Pharmacology. 564: 75-9. PMID 17350614 DOI: 10.1016/J.Ejphar.2007.01.087 |
0.365 |
|
2007 |
Pedersen K, Simonsen M, Østergaard SD, Munk OL, Rosa-Neto P, Olsen AK, Jensen SB, Møller A, Cumming P. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition. Neuroimage. 35: 38-46. PMID 17223363 DOI: 10.1016/J.Neuroimage.2006.11.038 |
0.447 |
|
2007 |
Vernaleken I, Weibrich C, Siessmeier T, Buchholz HG, Rösch F, Heinz A, Cumming P, Stoeter P, Bartenstein P, Gründer G. Asymmetry in dopamine D(2/3) receptors of caudate nucleus is lost with age. Neuroimage. 34: 870-8. PMID 17174574 DOI: 10.1016/J.Neuroimage.2006.10.013 |
0.356 |
|
2007 |
Vernaleken I, Buchholz HG, Kumakura Y, Siessmeier T, Stoeter P, Bartenstein P, Cumming P, Gründer G. 'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation. Human Brain Mapping. 28: 931-9. PMID 17133402 DOI: 10.1002/Hbm.20325 |
0.37 |
|
2006 |
Siessmeier T, Kienast T, Wrase J, Larsen JL, Braus DF, Smolka MN, Buchholz HG, Schreckenberger M, Rösch F, Cumming P, Mann K, Bartenstein P, Heinz A. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli. The European Journal of Neuroscience. 24: 305-13. PMID 16882026 DOI: 10.1111/J.1460-9568.2006.04903.X |
0.366 |
|
2006 |
Jakobsen S, Kodahl GM, Olsen AK, Cumming P. Synthesis, radiolabeling and in vivo evaluation of [11C]RAL-01, a potential phosphodiesterase 5 radioligand. Nuclear Medicine and Biology. 33: 593-7. PMID 16843833 DOI: 10.1016/J.Nucmedbio.2006.04.006 |
0.367 |
|
2006 |
Smith DF, Dyve S, Minuzzi L, Jakobsen S, Munk OL, Marthi K, Cumming P. Inhibition of [11C]mirtazapine binding by alpha2-adrenoceptor antagonists studied by positron emission tomography in living porcine brain. Synapse (New York, N.Y.). 59: 463-71. PMID 16565964 DOI: 10.1002/Syn.20262 |
0.405 |
|
2006 |
Iversen P, Hansen DA, Bender D, Rodell A, Munk OL, Cumming P, Keiding S. Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy. European Journal of Nuclear Medicine and Molecular Imaging. 33: 810-6. PMID 16550382 DOI: 10.1007/S00259-005-0052-8 |
0.373 |
|
2006 |
Cumming P, Pedersen MD, Minuzzi L, Mezzomo K, Danielsen EH, Iversen P, Aagaard D, Keiding S, Munk OL, Finsen B. Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography. Synapse (New York, N.Y.). 59: 418-26. PMID 16485266 DOI: 10.1002/Syn.20257 |
0.425 |
|
2006 |
Jensen SB, Olsen AK, Pedersen K, Cumming P. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride. Synapse (New York, N.Y.). 59: 427-34. PMID 16485265 DOI: 10.1002/Syn.20258 |
0.399 |
|
2006 |
Vernaleken I, Kumakura Y, Cumming P, Buchholz HG, Siessmeier T, Stoeter P, Müller MJ, Bartenstein P, Gründer G. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge. Neuroimage. 30: 1332-9. PMID 16439159 DOI: 10.1016/J.Neuroimage.2005.11.014 |
0.413 |
|
2006 |
Minuzzi L, Olsen AK, Bender D, Arnfred S, Grant R, Danielsen EH, Cumming P. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo. Synapse (New York, N.Y.). 59: 211-9. PMID 16385509 DOI: 10.1002/Syn.20234 |
0.452 |
|
2006 |
Doudet DJ, Rosa-Neto P, Munk OL, Ruth TJ, Jivan S, Cumming P. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study. Neuroimage. 30: 26-35. PMID 16378735 DOI: 10.1016/J.Neuroimage.2005.09.044 |
0.396 |
|
2006 |
Smith DF, Marthi K, Munk OL, Cumming P, Hansen SB, Jakobsen S. PET neuroimaging of [11C]mirtazapine enantiomers in pigs. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 350-7. PMID 16361085 DOI: 10.1016/J.Euroneuro.2005.10.008 |
0.372 |
|
2006 |
Kumakura Y, Gjedde A, Danielsen EH, Christensen S, Cumming P. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 26: 358-70. PMID 16079784 DOI: 10.1038/Sj.Jcbfm.9600202 |
0.378 |
|
2006 |
Peterson E, Gjedde A, Rodell A, Cumming P, Moller A, Linnet J. High sensation seeking men have increased dopamine binding in the right putamen during gambling, determined from raclopride binding potentials Neuroimage. 31: T168. DOI: 10.1016/J.Neuroimage.2006.04.151 |
0.337 |
|
2006 |
Smith DF, Marthi K, Jakobsen S, Bender D, Hansen S, Smith B, Hermansen F, Rosenberg R, Cumming P. PET neuroimaging of racemic [11C]mirtazapine and enantiomers: Pharmacokinetic models and alpha-noradrenergic binding sites Neuroimage. 31: T125. DOI: 10.1016/J.Neuroimage.2006.04.110 |
0.321 |
|
2006 |
Jakobsen S, Pedersen K, Smith DF, Jensen SB, Olsen AK, Cumming P. Detection of alphe-2 adrenergic receptora in brain of living pig with [11C]yohimbine Neuroimage. 31. DOI: 10.1016/J.Neuroimage.2006.04.109 |
0.311 |
|
2006 |
Pedersen K, Gjedde A, Olsen Å, Jakobsen S, Cumming P, Jensen S. Binding of the hallucinogen [11C]MeO-DMT in the brain of living pigs Neuroimage. 31: T53. DOI: 10.1016/J.Neuroimage.2006.04.044 |
0.337 |
|
2005 |
Borghammer P, Kumakura Y, Cumming P. Fluorodopa F 18 positron emission tomography and the progression of Parkinson disease. Archives of Neurology. 62: 1480; author reply 1. PMID 16157762 DOI: 10.1001/Archneur.62.9.1480-A |
0.334 |
|
2005 |
Heinz A, Siessmeier T, Wrase J, Buchholz HG, Gründer G, Kumakura Y, Cumming P, Schreckenberger M, Smolka MN, Rösch F, Mann K, Bartenstein P. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. The American Journal of Psychiatry. 162: 1515-20. PMID 16055774 DOI: 10.1176/Appi.Ajp.162.8.1515 |
0.353 |
|
2005 |
Lind NM, Gjedde A, Moustgaard A, Olsen AK, Jensen SB, Jakobsen S, Arnfred SM, Hansen AK, Hemmingsen RP, Cumming P. Behavioral response to novelty correlates with dopamine receptor availability in striatum of Göttingen minipigs. Behavioural Brain Research. 164: 172-7. PMID 16043240 DOI: 10.1016/J.Bbr.2005.06.008 |
0.4 |
|
2005 |
Siessmeier T, Zhou Y, Buchholz HG, Landvogt C, Vernaleken I, Piel M, Schirrmacher R, Rösch F, Schreckenberger M, Wong DF, Cumming P, Gründer G, Bartenstein P. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 964-72. PMID 15937307 |
0.313 |
|
2005 |
Sørensen M, Horsman MR, Cumming P, Munk OL, Keiding S. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors. International Journal of Radiation Oncology, Biology, Physics. 62: 854-61. PMID 15936570 DOI: 10.1016/J.Ijrobp.2005.02.044 |
0.323 |
|
2005 |
Andersen F, Watanabe H, Bjarkam C, Danielsen EH, Cumming P. Pig brain stereotaxic standard space: mapping of cerebral blood flow normative values and effect of MPTP-lesioning. Brain Research Bulletin. 66: 17-29. PMID 15925140 DOI: 10.1016/J.Brainresbull.2005.02.033 |
0.35 |
|
2005 |
Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J, Gjedde A. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage. 25: 868-76. PMID 15808987 DOI: 10.1016/J.Neuroimage.2004.11.031 |
0.342 |
|
2005 |
Minuzzi L, Nomikos GG, Wade MR, Jensen SB, Olsen AK, Cumming P. Interaction between LSD and dopamine D2/3 binding sites in pig brain. Synapse (New York, N.Y.). 56: 198-204. PMID 15803496 DOI: 10.1002/Syn.20141 |
0.45 |
|
2005 |
Gjedde A, Wong DF, Rosa-Neto P, Cumming P. Mapping neuroreceptors at work: on the definition and interpretation of binding potentials after 20 years of progress. International Review of Neurobiology. 63: 1-20. PMID 15797463 DOI: 10.1016/S0074-7742(05)63001-2 |
0.354 |
|
2005 |
Kumakura Y, Vernaleken I, Gründer G, Bartenstein P, Gjedde A, Cumming P. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 807-19. PMID 15729292 DOI: 10.1038/Sj.Jcbfm.9600079 |
0.415 |
|
2005 |
Lind NM, Olsen AK, Moustgaard A, Jensen SB, Jakobsen S, Hansen AK, Arnfred SM, Hemmingsen RP, Gjedde A, Cumming P. Mapping the amphetamine-evoked dopamine release in the brain of the Göttingen minipig. Brain Research Bulletin. 65: 1-9. PMID 15680539 DOI: 10.1016/J.Brainresbull.2004.08.007 |
0.398 |
|
2005 |
Jelsing J, Olsen AK, Cumming P, Gjedde A, Hansen AK, Arnfred S, Hemmingsen R, Pakkenberg B. A volumetric screening procedure for the Göttingen minipig brain. Experimental Brain Research. 162: 428-35. PMID 15668795 DOI: 10.1007/S00221-004-2026-7 |
0.305 |
|
2005 |
Vernaleken I, Kumakura Y, Buchholz H, Siessmeier T, Bartenstein P, Cumming P, Gründer G. Prefrontal cognitive performance of healthy subjects positively correlates with 18F-FDOPA uptake in positron emission tomography Pharmacopsychiatry. 38. DOI: 10.1055/S-2005-918861 |
0.329 |
|
2004 |
Kumakura Y, Danielsen EH, Reilhac A, Gjedde A, Cumming P. Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease. Acta Neurologica Scandinavica. 110: 188-95. PMID 15285777 DOI: 10.1111/J.1600-0404.2004.00299.X |
0.43 |
|
2004 |
Rosa-Neto P, Gjedde A, Olsen AK, Jensen SB, Munk OL, Watanabe H, Cumming P. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain. Synapse (New York, N.Y.). 53: 222-33. PMID 15266554 DOI: 10.1002/Syn.20053 |
0.448 |
|
2004 |
Rosa-Neto P, Olsen AK, Gjedde A, Watanabe H, Cumming P. MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia. Synapse (New York, N.Y.). 53: 214-21. PMID 15266553 DOI: 10.1002/Syn.20052 |
0.389 |
|
2004 |
Bender D, Olsen AK, Marthi MK, Smith DF, Cumming P. PET evaluation of the uptake of N-[11C]methyl CP-643,051, an NK1 receptor antagonist, in the living porcine brain. Nuclear Medicine and Biology. 31: 699-704. PMID 15246360 DOI: 10.1016/J.Nucmedbio.2004.03.005 |
0.377 |
|
2004 |
Rosa-Neto P, Doudet DJ, Cumming P. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET. Neuroimage. 22: 1076-83. PMID 15219579 DOI: 10.1016/J.Neuroimage.2004.03.004 |
0.434 |
|
2004 |
Vafaee MS, ØStergaard K, Sunde N, Gjedde A, Dupont E, Cumming P. Focal changes of oxygen consumption in cerebral cortex of patients with Parkinson's disease during subthalamic stimulation. Neuroimage. 22: 966-74. PMID 15193628 DOI: 10.1016/J.Neuroimage.2004.02.019 |
0.336 |
|
2004 |
Lou HC, Rosa P, Pryds O, Karrebaek H, Lunding J, Cumming P, Gjedde A. ADHD: increased dopamine receptor availability linked to attention deficit and low neonatal cerebral blood flow. Developmental Medicine and Child Neurology. 46: 179-83. PMID 14995087 DOI: 10.1017/S0012162204000313 |
0.343 |
|
2003 |
Kretzschmar M, Brust P, Zessin J, Cumming P, Bergmann R, Johannsen B. Autoradiographic imaging of the serotonin transporter in the brain of rats and pigs using S-([18F]fluoromethyl)-(+)-McN5652. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 387-97. PMID 12957338 DOI: 10.1016/S0924-977X(03)00039-7 |
0.419 |
|
2003 |
Cumming P, Rosa-Neto P, Watanabe H, Smith D, Bender D, Clarke PB, Gjedde A. Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain. Neuroimage. 19: 1127-36. PMID 12880838 DOI: 10.1016/S1053-8119(03)00079-X |
0.405 |
|
2003 |
Cumming P, Gillings NM, Jensen SB, Bjarkam C, Gjedde A. Kinetics of the uptake and distribution of the dopamine D(2,3) agonist (R)-N-[1-(11)C]n-propylnorapomorphine in brain of healthy and MPTP-treated Göttingen miniature pigs. Nuclear Medicine and Biology. 30: 547-53. PMID 12831994 DOI: 10.1016/S0969-8051(02)00448-1 |
0.461 |
|
2003 |
Jensen SB, Smith DF, Bender D, Jakobsen S, Peters D, Nielsen EØ, Olsen GM, Scheel-Krüger J, Wilson A, Cumming P. [11C]-NS 4194 versus [11C]-DASB for PET imaging of serotonin transporters in living porcine brain. Synapse (New York, N.Y.). 49: 170-7. PMID 12774301 DOI: 10.1002/Syn.10222 |
0.399 |
|
2003 |
Gründer G, Vernaleken I, Müller MJ, Davids E, Heydari N, Buchholz HG, Bartenstein P, Munk OL, Stoeter P, Wong DF, Gjedde A, Cumming P. Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 787-94. PMID 12655326 DOI: 10.1038/Sj.Npp.1300103 |
0.418 |
|
2003 |
Audrain H, Bender D, Scheel-Krüger J, Nielsen E, Olsen GM, Peters D, Cumming P. Synthesis of the serotonin transporter ligand (±)-10-methyl 3-[6-nitro-(2-quinolinyl)]-3,10-diazabicyclo-[4.3.1]-decane ([ 11C-methyl]NS 2495) and first in vivo results Journal of Labelled Compounds and Radiopharmaceuticals. 46: 873-882. DOI: 10.1002/Jlcr.726 |
0.384 |
|
2002 |
Dall AM, Danielsen EH, Sørensen JC, Andersen F, Møller A, Zimmer J, Gjedde AH, Cumming P. Quantitative [18F]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs. Cell Transplantation. 11: 733-46. PMID 12588105 DOI: 10.3727/000000002783985314 |
0.326 |
|
2002 |
Pradhan AA, Cumming P, Clarke PB. [125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents. Brain Research. 954: 227-36. PMID 12414106 DOI: 10.1016/S0006-8993(02)03340-1 |
0.358 |
|
2002 |
Cumming P, Wong DF, Dannals RF, Gillings N, Hilton J, Scheffel U, Gjedde A. The competition between endogenous dopamine and radioligands for specific binding to dopamine receptors. Annals of the New York Academy of Sciences. 965: 440-50. PMID 12105119 DOI: 10.1111/J.1749-6632.2002.Tb04185.X |
0.402 |
|
2002 |
Rosa Neto P, Lou H, Cumming P, Pryds O, Gjedde A. Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit. Annals of the New York Academy of Sciences. 965: 434-9. PMID 12105118 DOI: 10.1111/J.1749-6632.2002.Tb04184.X |
0.377 |
|
2002 |
Cumming P, Wong DF, Gillings N, Hilton J, Scheffel U, Gjedde A. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 22: 596-604. PMID 11973432 DOI: 10.1097/00004647-200205000-00011 |
0.395 |
|
2001 |
Watanabe H, Andersen F, Simonsen CZ, Evans SM, Gjedde A, Cumming P. MR-based statistical atlas of the Göttingen minipig brain. Neuroimage. 14: 1089-96. PMID 11697940 DOI: 10.1006/Nimg.2001.0910 |
0.376 |
|
2001 |
Dagher A, Bleicher C, Aston JA, Gunn RN, Clarke PB, Cumming P. Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse (New York, N.Y.). 42: 48-53. PMID 11668590 DOI: 10.1002/Syn.1098 |
0.363 |
|
2001 |
Danielsen EH, Smith DF, Andersen F, Gee AD, Bender D, Hansen SB, Hermansen F, Østergaard L, Cumming P, Gjedde A. FDOPA metabolism in the adult porcine brain: influence of tracer circulation time and VOI selection on estimates of striatal DOPA decarboxylation. Journal of Neuroscience Methods. 111: 157-68. PMID 11595282 DOI: 10.1016/S0165-0270(01)00453-8 |
0.384 |
|
2001 |
Danielsen EH, Smith D, Hermansen F, Gjedde A, Cumming P. Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo. Synapse (New York, N.Y.). 41: 172-5. PMID 11400183 DOI: 10.1002/Syn.1071 |
0.422 |
|
2001 |
Cumming P, Munk OL, Doudet D. Loss of metabolites from monkey striatum during PET with FDOPA. Synapse (New York, N.Y.). 41: 212-8. PMID 11391782 DOI: 10.1002/Syn.1077 |
0.369 |
|
2001 |
Cumming P, Danielsen EH, Vafaee M, Falborg L, Steffensen E, Sørensen JC, Gillings N, Bender D, Marthi K, Andersen F, Munk O, Smith D, Møller A, Gjedde A. Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal grafts. Acta Neurologica Scandinavica. 103: 309-15. PMID 11328207 DOI: 10.1034/J.1600-0404.2001.103005309.X |
0.417 |
|
2001 |
Smith DF, Bender D, Marthi K, Cumming P, Hansen SB, Peters D, Nielsen EO, Scheel-Krüger J, Gjedde A. Synthesis and evaluation of racemic [(11)C]NS2456 and enantiomers as selective serotonin reuptake radiotracers for PET. Nuclear Medicine and Biology. 28: 265-70. PMID 11323236 DOI: 10.1016/S0969-8051(00)00175-X |
0.423 |
|
2001 |
Gillings NM, Bender D, Falborg L, Marthi K, Munk OL, Cumming P. Kinetics of the metabolism of four PET radioligands in living minipigs. Nuclear Medicine and Biology. 28: 97-104. PMID 11182570 DOI: 10.1016/S0969-8051(00)00187-6 |
0.311 |
|
2001 |
Cumming P, Kretzschmar M, Brust P, Smith DF. Quantitative radioluminography of serotonin uptake sites in the porcine brain. Synapse (New York, N.Y.). 39: 351-5. PMID 11169786 DOI: 10.1002/1098-2396(20010315)39:4<351::Aid-Syn1019>3.0.Co;2-M |
0.39 |
|
2001 |
Smith DF, Bender D, Marthi K, Cumming P, Hansen SB, Peters D, Nielsen EØ, Scheel-Krüger J, Gjedde A. Synthesis and in vivo evaluation (PIG) of the selective seretonin reuptake inhibitor [11C]NS 2456 Journal of Labelled Compounds and Radiopharmaceuticals. 44: S198-S200. DOI: 10.1002/Jlcr.2580440169 |
0.394 |
|
2000 |
Ishizu K, Smith DF, Bender D, Danielsen E, Hansen SB, Wong DF, Cumming P, Gjedde A. Positron emission tomography of radioligand binding in porcine striatum in vivo: haloperidol inhibition linked to endogenous ligand release. Synapse (New York, N.Y.). 38: 87-101. PMID 10941144 DOI: 10.1002/1098-2396(200010)38:1<87::Aid-Syn10>3.0.Co;2-C |
0.398 |
|
2000 |
Rousset OG, Deep P, Kuwabara H, Evans AC, Gjedde AH, Cumming P. Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects. Synapse (New York, N.Y.). 37: 81-9. PMID 10881028 DOI: 10.1002/1098-2396(200008)37:2<81::Aid-Syn1>3.0.Co;2-# |
0.429 |
|
2000 |
Danielsen EH, Cumming P, Andersen F, Bender D, Brevig T, Falborg L, Gee A, Gillings NM, Hansen SB, Hermansen F, Johansen J, Johansen TE, Dahl-Jørgensen A, Jørgensen HA, Meyer M, et al. The DaNeX study of embryonic mesencephalic, dopaminergic tissue grafted to a minipig model of Parkinson's disease: preliminary findings of effect of MPTP poisoning on striatal dopaminergic markers. Cell Transplantation. 9: 247-59. PMID 10811397 DOI: 10.1177/096368970000900210 |
0.3 |
|
2000 |
Marenco T, Bernstein S, Cumming P, Clarke PB. Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely-moving rats. British Journal of Pharmacology. 129: 147-55. PMID 10694214 DOI: 10.1038/Sj.Bjp.0703005 |
0.309 |
|
1999 |
Deep P, Dagher A, Sadikot A, Gjedde A, Cumming P. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine. Synapse (New York, N.Y.). 34: 313-8. PMID 10529725 DOI: 10.1002/(Sici)1098-2396(19991215)34:4<313::Aid-Syn7>3.0.Co;2-1 |
0.418 |
|
1999 |
Cumming P, Hermansen F, Gjedde A. Cerebral dopamine concentrations during levodopa treatment. Neurology. 53: 1374-5. PMID 10522916 DOI: 10.1212/Wnl.53.6.1374 |
0.313 |
|
1999 |
Cumming P, Yokoi F, Chen A, Deep P, Dagher A, Reutens D, Kapczinski F, Wong DF, Gjedde A. Pharmacokinetics of radiotracers in human plasma during positron emission tomography. Synapse (New York, N.Y.). 34: 124-34. PMID 10502311 DOI: 10.1002/(Sici)1098-2396(199911)34:2<124::Aid-Syn5>3.0.Co;2-O |
0.381 |
|
1999 |
Danielsen EH, Smith DF, Gee AD, Venkatachalam TK, Hansen SB, Hermansen F, Gjedde A, Cumming P. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography. Synapse (New York, N.Y.). 33: 247-58. PMID 10421705 DOI: 10.1002/(Sici)1098-2396(19990915)33:4<247::Aid-Syn1>3.0.Co;2-6 |
0.402 |
|
1998 |
Léger G, Gjedde A, Kuwabara H, Guttman M, Cumming P. Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness. Synapse (New York, N.Y.). 30: 351-61. PMID 9826227 DOI: 10.1002/(Sici)1098-2396(199812)30:4<351::Aid-Syn2>3.0.Co;2-2 |
0.436 |
|
1998 |
Cumming P, Ase A, Kuwabara H, Gjedde A. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 491-9. PMID 9591841 DOI: 10.1097/00004647-199805000-00004 |
0.417 |
|
1998 |
Reith J, Cumming P, Gjedde A. Enhanced [3H]DOPA and [3H]dopamine turnover in striatum and frontal cortex in vivo linked to glutamate receptor antagonism. Journal of Neurochemistry. 70: 1979-85. PMID 9572282 DOI: 10.1046/J.1471-4159.1998.70051979.X |
0.395 |
|
1998 |
Cumming P, Gjedde A. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse (New York, N.Y.). 29: 37-61. PMID 9552174 DOI: 10.1002/(Sici)1098-2396(199805)29:1<37::Aid-Syn4>3.0.Co;2-C |
0.415 |
|
1997 |
Cumming P, Deep P, Rousset O, Evans A, Gjedde A. On the rate of decarboxylation of dopa to dopamine in living mammalian brain. Annals of the New York Academy of Sciences. 835: 274-308. PMID 9616781 DOI: 10.1111/J.1749-6632.1997.Tb48637.X |
0.379 |
|
1997 |
Deep P, Kuwabara H, Gjedde A, Cumming P. The kinetic behaviour of [3H]DOPA in living rat brain investigated by compartmental modelling of static autoradiograms. Journal of Neuroscience Methods. 78: 157-68. PMID 9497012 DOI: 10.1016/S0165-0270(97)00147-7 |
0.381 |
|
1997 |
Cumming P, Ase A, Laliberté C, Kuwabara H, Gjedde A. In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 1254-60. PMID 9390657 DOI: 10.1097/00004647-199711000-00014 |
0.408 |
|
1997 |
Deep P, Gjedde A, Cumming P. On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo. Journal of Neuroscience Methods. 76: 157-65. PMID 9350967 DOI: 10.1016/S0165-0270(97)00094-0 |
0.327 |
|
1997 |
Cumming P, Ljubic-Thibal V, Laliberté C, Diksic M. The effect of unilateral neurotoxic lesions to serotonin fibres in the medial forebrain bundle on the metabolism of [3H]DOPA in the telencephalon of the living rat. Brain Research. 747: 60-9. PMID 9042528 DOI: 10.1016/S0006-8993(96)01227-9 |
0.342 |
|
1997 |
Benkelfat C, Nishizawa S, Kuwabara H, Lal S, Chouinard G, Cumming P, Labelle A, Joober R, Bruce K, Dikksic M, Gjedde A. Brain dopa-decarboxylase (DDC) activity in unmedicated schizophrenic patients Schizophrenia Research. 24: 176. DOI: 10.1016/S0920-9964(97)82505-4 |
0.324 |
|
1997 |
Reith J, Cumming P, Gjedde A. 2-30-26 Chronic glutamate receptor antagonism linked to markedly enhanced activities of enzymes of dopamine synthesis and breakdown in vivo Journal of the Neurological Sciences. 150: S114. DOI: 10.1016/S0022-510X(97)85404-4 |
0.308 |
|
1995 |
Cumming P, Kuwabara H, Ase A, Gjedde A. Regulation of DOPA decarboxylase activity in brain of living rat. Journal of Neurochemistry. 65: 1381-90. PMID 7643116 DOI: 10.1046/J.1471-4159.1995.65031381.X |
0.385 |
|
1995 |
Cumming P, Ase A, Diksic M, Harrison J, Jolly D, Kuwabara H, Laliberté C, Gjedde A. Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat. Biochemical Pharmacology. 50: 943-6. PMID 7575677 DOI: 10.1016/0006-2952(95)00216-M |
0.392 |
|
1994 |
Cumming P, Gjedde A. Subclasses of histamine H3 antagonist binding sites in rat brain. Brain Research. 641: 203-7. PMID 8012822 DOI: 10.1016/0006-8993(94)90147-3 |
0.339 |
|
1994 |
Cumming P, Gjedde A, Vincent S. Histamine H3 binding sites in rat brain: localization in the nucleus of the solitary tract. Brain Research. 641: 198-202. PMID 8012821 DOI: 10.1016/0006-8993(94)90146-5 |
0.586 |
|
1994 |
Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F, Bachneff S, Cumming P, Diksic M, Dyve SE, Etienne P, Evans AC, Lal S, Shevell M, Savard G, et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proceedings of the National Academy of Sciences of the United States of America. 91: 11651-4. PMID 7972118 DOI: 10.1073/Pnas.91.24.11651 |
0.364 |
|
1994 |
Cumming P, Kuwabara H, Gjedde A. A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat. Journal of Neurochemistry. 63: 1675-82. PMID 7931323 DOI: 10.1046/J.1471-4159.1994.63051675.X |
0.327 |
|
1994 |
Cumming P, Venkatachalam TK, Rajagopal S, Diksic M, Gjedde A. Brain uptake of alpha-[14C]methyl-para-tyrosine in the rat. Synapse (New York, N.Y.). 17: 125-8. PMID 7916491 DOI: 10.1002/Syn.890170208 |
0.359 |
|
1994 |
Cumming P, Laliberté C, Gjedde A. Distribution of histamine H3 binding in forebrain of mouse and guinea pig. Brain Research. 664: 276-9. PMID 7895042 DOI: 10.1016/0006-8993(94)91985-2 |
0.333 |
|
1993 |
Hoshi H, Kuwabara H, Léger G, Cumming P, Guttman M, Gjedde A. 6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 13: 57-69. PMID 8417011 DOI: 10.1038/Jcbfm.1993.8 |
0.319 |
|
1993 |
Kuwabara H, Cumming P, Reith J, Léger G, Diksic M, Evans AC, Gjedde A. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 13: 43-56. PMID 8417009 DOI: 10.1038/Jcbfm.1993.7 |
0.422 |
|
1993 |
Cumming P, Vincent SR. Altered histamine H3 binding in rat forebrain after reserpine treatment. Brain Research. 602: 53-6. PMID 8383572 DOI: 10.1016/0006-8993(93)90240-N |
0.589 |
|
1993 |
Gjedde A, Léger GC, Cumming P, Yasuhara Y, Evans AC, Guttman M, Kuwabara H. Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis. Journal of Neurochemistry. 61: 1538-41. PMID 8377003 DOI: 10.1111/J.1471-4159.1993.Tb13651.X |
0.351 |
|
1993 |
Cumming P, Léger GC, Kuwabara H, Gjedde A. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 13: 668-75. PMID 8314919 DOI: 10.1038/Jcbfm.1993.85 |
0.33 |
|
1993 |
Cumming P, Gjedde A. Kinetics of the uptake of [3H]paroxetine in the rat brain. Synapse (New York, N.Y.). 15: 124-9. PMID 8259523 DOI: 10.1002/Syn.890150204 |
0.387 |
|
1992 |
Cumming P, Vincent SR. Inhibition of histamine-N-methyltransferase (HNMT) by fragments of 9-amino-1,2,3,4-tetrahydroacridine (tacrine) and by beta-carbolines. Biochemical Pharmacology. 44: 989-92. PMID 1530666 DOI: 10.1016/0006-2952(92)90133-4 |
0.557 |
|
1992 |
Cumming P, Brown E, Damsma G, Fibiger H. Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study. Journal of Neurochemistry. 59: 1905-14. PMID 1383428 DOI: 10.1111/J.1471-4159.1992.Tb11026.X |
0.344 |
|
1991 |
Cumming P, Damsma G, Fibiger HC, Vincent SR. Characterization of extracellular histamine in the striatum and bed nucleus of the stria terminalis of the rat: an in vivo microdialysis study. Journal of Neurochemistry. 56: 1797-803. PMID 1707442 DOI: 10.1111/J.1471-4159.1991.Tb02083.X |
0.587 |
|
1991 |
Cumming P, Shaw C, Vincent SR. High affinity histamine binding site is the H3 receptor: characterization and autoradiographic localization in rat brain. Synapse (New York, N.Y.). 8: 144-51. PMID 1652795 DOI: 10.1002/Syn.890080208 |
0.586 |
|
1990 |
Cumming P, Reiner PB, Vincent SR. Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA). Biochemical Pharmacology. 40: 1345-50. PMID 2403387 DOI: 10.1016/0006-2952(90)90402-7 |
0.595 |
|
1990 |
Cumming P, Damsma G, Fibiger HC, Vincent SR. Determination of histamine in cerebral dialysates from the rat European Journal of Pharmacology. 183: 442. DOI: 10.1016/0014-2999(90)93329-O |
0.542 |
|
1989 |
Cumming P, Jakubovic A, Vincent SR. Cerebral histamine levels are unaffected by MPTP administration in the mouse. European Journal of Pharmacology. 166: 299-301. PMID 2792195 DOI: 10.1016/0014-2999(89)90071-X |
0.599 |
|
1988 |
Cumming P, Häusser M, Martin WR, Grierson J, Adam MJ, Ruth TJ, McGeer EG. Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat. Biochemical Pharmacology. 37: 247-50. PMID 3124856 DOI: 10.1016/0006-2952(88)90725-3 |
0.345 |
|
1987 |
Cumming P, Boyes BE, Martin WR, Adam M, Ruth TJ, McGeer EG. Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521. Biochemical Pharmacology. 36: 2527-31. PMID 3111485 DOI: 10.1016/0006-2952(87)90526-0 |
0.375 |
|
1987 |
Cumming P, Kamo H, McGeer EG, McGeer PL. Toxicity of p-methoxyphenol to dopamine neurons in the rat substantia nigra. Neuropharmacology. 26: 1795-7. PMID 2893988 DOI: 10.1016/0028-3908(87)90136-5 |
0.348 |
|
1987 |
Radke JM, Cumming P, Vincent SR. Effects of MPTP poisoning on central somatostatin and substance P levels in the mouse. European Journal of Pharmacology. 134: 105-8. PMID 2435563 DOI: 10.1016/0014-2999(87)90137-3 |
0.565 |
|
1986 |
Boyes BE, Cumming P, Martin WR, McGeer EG. Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects. Life Sciences. 39: 2243-52. PMID 3097437 DOI: 10.1016/0024-3205(86)90403-0 |
0.328 |
|
1986 |
Cumming P, Von Krosigk M, Reiner PB, McGeer EG, Vincent SR. Absence of adrenaline neurons in the guinea pig brain: a combined immunohistochemical and high-performance liquid chromatography study. Neuroscience Letters. 63: 125-30. PMID 2869455 DOI: 10.1016/0304-3940(86)90048-0 |
0.57 |
|
Show low-probability matches. |